Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
(2003) In European Journal of Clinical Pharmacology 59(2). p.151-156
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/114225
- author
- Piitulainen, Eeva LU ; Bernspång, Elisabeth LU ; Björkman, Sven and Berntorp, Erik LU
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Clinical Pharmacology
- volume
- 59
- issue
- 2
- pages
- 151 - 156
- publisher
- Springer
- external identifiers
-
- wos:000184157900011
- pmid:12728289
- scopus:0038391385
- ISSN
- 1432-1041
- DOI
- 10.1007/s00228-003-0589-z
- language
- English
- LU publication?
- yes
- id
- a7e6dbdc-b902-4f9c-85c1-840666e1a9e6 (old id 114225)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12728289&dopt=Abstract
- date added to LUP
- 2016-04-01 16:58:39
- date last changed
- 2022-05-08 21:56:43
@article{a7e6dbdc-b902-4f9c-85c1-840666e1a9e6,
author = {{Piitulainen, Eeva and Bernspång, Elisabeth and Björkman, Sven and Berntorp, Erik}},
issn = {{1432-1041}},
language = {{eng}},
number = {{2}},
pages = {{151--156}},
publisher = {{Springer}},
series = {{European Journal of Clinical Pharmacology}},
title = {{Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.}},
url = {{http://dx.doi.org/10.1007/s00228-003-0589-z}},
doi = {{10.1007/s00228-003-0589-z}},
volume = {{59}},
year = {{2003}},
}